{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:26:25Z","timestamp":1791779185829,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","heartrhythmjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.hrthm.2024.11.035","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T16:02:53Z","timestamp":1732291373000},"page":"979-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Reduced direct oral anticoagulant dose vs dual antiplatelet therapy after left atrial appendage closure in patients with nonvalvular atrial fibrillation: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"22","author":[{"given":"N\u00e1gila A.","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco W.P.A.","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz X.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente L.M.","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 L.B.","family":"d\u2019Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2024.11.035_bib1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.11.035_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.11.035_bib3","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.4244\/EIJ-D-22-00627","article-title":"Left atrial appendage occlusion","volume":"18","author":"Holmes","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.hrthm.2024.11.035_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.11.035_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of device-related thrombus following percutaneous left atrial appendage occlusion","volume":"78","author":"Simard","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.11.035_bib6","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jcin.2015.08.035","article-title":"Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: a pooled, patient-level analysis of the WATCHMAN randomized trial experience","volume":"8","author":"Price","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2024.11.035_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005359","article-title":"Percutaneous left atrial appendage closure: current devices and clinical outcomes","volume":"10","author":"Asmarats","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2024.11.035_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.amjcard.2022.08.012","article-title":"Meta-analysis comparing left atrial appendage occlusion, direct oral anticoagulants, and warfarin for nonvalvular atrial fibrillation","volume":"186","author":"Abdelfattah","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2024.11.035_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/heartjnl-2016-309782","article-title":"Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials","volume":"103","author":"Sahay","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2024.11.035_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.034815","article-title":"Left atrial appendage closure compared with oral anticoagulants for patients with atrial fibrillation: a systematic review and network meta-analysis","volume":"13","author":"Oliva","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2024.11.035_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.11.035_bib12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/2046-4053-2-82","article-title":"Cochrane diagnostic test accuracy reviews","volume":"2","author":"Leeflang","year":"2013","journal-title":"Syst Rev"},{"key":"10.1016\/j.hrthm.2024.11.035_bib13","article-title":"Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist","volume":"370","author":"Salameh","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2024.11.035_bib14","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hrthm.2024.11.035_bib15","article-title":"RoB 2: a revised tool for assessing risk of bias in randomized trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2024.11.035_bib16","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2024.11.035_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008481","article-title":"Reduced rivaroxaban dose versus dual antiplatelet therapy after left atrial appendage closure: ADRIFT a randomized pilot study","volume":"13","author":"Duthoit","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2024.11.035_bib18","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamacardio.2024.2335","article-title":"Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: the ADALA randomized clinical trial","volume":"9","author":"Freixa","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2024.11.035_bib19","first-page":"142","article-title":"Low dose of direct oral anticoagulants after left atrial appendage occlusion","volume":"8","author":"Cepas-Guillen","year":"2021","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.hrthm.2024.11.035_bib20","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","article-title":"Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion","volume":"14","author":"Della Rocca","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2024.11.035_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.31083\/j.rcm2411335","article-title":"Clinical effectiveness and safety comparison between reduced rivaroxaban dose and dual antiplatelet therapy for nonvalvular atrial fibrillation patients following percutaneous left atrial appendage closure: a prospective observational study","volume":"24","author":"Li","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2024.11.035_bib22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jcin.2018.11.001","article-title":"Antithrombotic therapy and device-related thrombosis following endovascular left atrial appendage closure","volume":"12","author":"Saw","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2024.11.035_bib23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of device-related thrombus following percutaneous left atrial appendage occlusion","volume":"78","author":"Simard","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.11.035_bib24","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"Dukkipati","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.11.035_bib25","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation","volume":"71","author":"Fauchier","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.11.035_bib26","doi-asserted-by":"crossref","first-page":"E1019","DOI":"10.1002\/ccd.29458","article-title":"Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device: insights from the EWOLUTION real world registry","volume":"97","author":"Sedaghat","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"issue":"24","key":"10.1016\/j.hrthm.2024.11.035_bib27","first-page":"00247","article-title":"Early and late hospital readmissions after percutaneous left atrial appendage closure","volume":"9","author":"Trinh","year":"2024","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.hrthm.2024.11.035_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/2046-4053-1-41","article-title":"Sample size and power considerations in network meta-analysis","volume":"1","author":"Thorlund","year":"2012","journal-title":"Syst Rev"},{"key":"10.1016\/j.hrthm.2024.11.035_bib29","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","article-title":"Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation","volume":"79","author":"Freeman","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.11.035_bib30","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2023.08.010","article-title":"Network meta-analysis of initial antithrombotic regimens after left atrial appendage occlusion","volume":"82","author":"Carvalho","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.11.035_bib31","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/jcm12030847","article-title":"Reduced- or half-dose rivaroxaban following left atrial appendage closure: a feasible antithrombotic therapy in patients at high risk of bleeding?","volume":"12","author":"Zhou","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.hrthm.2024.11.035_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.11.035_bib33","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF Trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154752712403618X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154752712403618X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T07:06:07Z","timestamp":1744441567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154752712403618X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S154752712403618X"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.11.035","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced direct oral anticoagulant dose vs dual antiplatelet therapy after left atrial appendage closure in patients with nonvalvular atrial fibrillation: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}